Acepodia, Inc. (TPEX:6976)
Taiwan · Delayed Price · Currency is TWD 17.85
+1.50 (9.17%)
Sep 5, 2025, 2:00 PM CST
Acepodia Market Cap
Acepodia has a market cap or net worth of 10.52 billion as of September 5, 2025. Its market cap has decreased by -21.83% in one year.
Market Cap
10.52B
Enterprise Value
5.68B
Revenue
301.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
17.85
Market Cap Chart
Since August 8, 2023, Acepodia's market cap has decreased from 22.92B to 10.52B, a decrease of -54.10%. That is a compound annual growth rate of -31.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 10.52B | 5.48% |
| Dec 31, 2024 | 9.98B | -48.47% |
| Dec 29, 2023 | 19.36B | -15.54% |
| Aug 8, 2023 | 22.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 378.45B |
| PharmaEssentia | 172.96B |
| Bora Pharmaceuticals Co., LTD. | 91.46B |
| Lotus Pharmaceutical | 51.15B |
| Lumosa Therapeutics | 40.18B |
| Oneness Biotech | 35.77B |
| Polaris Group | 29.31B |
| Center Laboratories | 28.67B |